Inflammation of the arteries is a primary precursor and driver of cardiovascular disease — the No. 1 killer of people in the United States. This inflammation is associated with the buildup of dangerous plaque inside the arteries. Advanced treatments are needed to target this inflammation in patients. Michigan State University researchers have tested a new nanoparticle nanotherapy infusion that precisely targets inflammation and activates the immune system to help clear out arterial plaque.
Artery view before and after nanotherapy infusion
MSU College of Engineering Media and Public Relations page